The Trump administration may have dropped the drug rebate rule last year, but the American people haven’t given up their search for security.
Healthcare is a $3.5 trillion industry projected to balloon even more in the next decade and consumers are finally saying “enough is enough.” They’re speaking out against unsustainable costs and directing a sizable portion of their frustration toward the pharmaceutical industry. Eight in ten Americans now say prescription drug prices are “unreasonable,” as pharma scrambles to build a legislative firewall by putting significant sums of money behind candidates who will protect their interests.
